Assessment of EGFR and TGF-alpha expression in relationship to HPV status and Ki-67 distribution in cervical intraepithelial neoplasms

International Journal of Cancer

Volumn 69, Issue 3, 1996, Pages 165-169

  Dellas, Athanassios ^a   Schultheiss, Elisabeth ^a   Almendral, Alfonso C ^a   Torhorst, Joachim ^a   Gudat, Fred ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY KI 67; TRANSFORMING GROWTH FACTOR ALPHA; VIRUS DNA;

ARTICLE; CANCER GRADING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; WART VIRUS;

CARCINOMA IN SITU; CELL DIVISION; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PAPILLOMAVIRIDAE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 0030055596     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960621)69:3<165::AID-IJC2>3.0.CO;2-Y     Document Type: Article

References (22)

1. AL-SALEH, W., DELVENNE, P., GREIMERS, R., FRIDMAN, V., DOYEN, J. and BONIVER, J., Assessment of Ki-67-antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Correlation with the histologic grade and human papillomavirus type. Amer. J. clin. Pathol., 104, 154-160 (1995).
2. BATES, S.E., VALVERIUS, E.M., ENNIS, B.W., BRONZERT, D.A., SHERIDAN, J.P., STAMPFER, M.R., MENDELSOHN, J., LIPPMAN, M.E. and DICKSON, R.B., Expression of the transforming-growth-factor-alpha/ epidermal-growth-factor-receptor pathway in normal human breast epithelial cells. Endocrinology, 126, 596-607 (1990).
3. BROWN, C.L., RUBIN, M., MASUI, H. and MENDELSOHN, J., Growth inhibition by anti-EGF-receptor monoclonal antibody in squamous cervical carcinoma cells expressing TGF-α. Proc, Amer, Ass. Cancer Res., 35, 381, A2270 (1994).
4. BROWN, D.C., COLE, D.J., GATTER, K.C. and MASON, D.Y., Carcinoma of the cervix: an assessment of tumour proliferation using the monoclonal antibody Ki-67. Brit. J. Cancer, 57, 178-181 (1988).
5. CIARDIELLO, F., MCGEADY, M.L., KIM, N., BASOLO, F., HYNES, N., LANGTON, B.C., YOKOZAKI, H., SAEKI, T., ELLIOTT, J.W. and MASUI, H., Transforming-growth-factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras proto-oncogene but not by the c-neu proto-oncogene, and over-expression of the transforming-growth-factor-alpha complementary DNA leads to transformation. Cell Growth Differ. 1, 407-420 (1990).
6. DE LARCO, J. and TODARO, G., Growth factors from murine sarcoma virus-transformed cells. Proc. nat. Acad. Sci. (Wash.), 75, 4001-4005 (1978).
7. ENNIS, B., VALVERIUS, E., LIPPMAN, M., BELLOT, F., KRIS, R., SCHLESSINGER, J., MASUI, H., GOLDENBERG, A., MENDELSOHN, J. and DICKSON, R., Monoclonal anti-EGF-receptor antibodies inhibit the growth of malignant and non-malignant human mammary epithelial cells. Mol. Endocrinol, 3, 1830-1838 (1989).
8. GATTER, K.C., DUNNILL, M.S., GERDES, J., STEIN, H. and MASON, D.Y., New approach to assessing lung tumours in man. J. clin. Pathol., 39, 590-593 (1986).
9. GERDES, J., LELLE, R.J. and PICKARTZ, H., Growth fractions in breast cancer determined in situ with the monoclonal antibody Ki-67. J. clin. Pathol., 39, 977-980 (1986).
10. GERDES, J., LEMKE, H., BAISCH, H., WACKER, H.-H., SCHWAB, U. and STEIN, H., Cell-cycle analysis of a cell-proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol., 133, 1710-1715 (1984).
11. HARRIS, A.L., NICHOLSON, S., SAINSBURY, J.R.C., FARNDON, J. and WRIGHT, C., Epidermal-growth-factor receptor: a marker of early relapse in breast cancer and tumor-stage progression in bladder-cancer interactions with neu. In: M. Furth and M. Greaves (eds.), The molecular diagnostics of human cancer, Vol. 7, pp. 353-357, Cold Spring Harbor Laboratory, NY (1989).
12. LEECHANACHAI, P., BANKS, L., MOREAU, F. and MATLASHEWSKI, G., The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth-factor-mediated signal transduction to the nucleus. Oncogene, 7, 19-25 (1992).
13. LUETTEKE, N.C. and LEE, D.C., Transforming growth factor alpha: expression, regulation and biological action of its integral membrane precursor. Semin. Cancer. Biol., 1, 265-275 (1990).
14. MENDELSOHN, J. and LIPPMAN, M., Principles of molecular cell biology of cancer: growth factors. In: V.J. DeVita, S. Hellman and S. Rosenberg (eds.), Cancer: principles and practice of oncology. Vol. 1, pp. 114-133, J.B. Lippincott, Philadelphia (1993).
15. NEAL, D.E., BENNETT, M.K. and HALL, R.R., Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet, 1, 366-368 (1985).
16. OZANNE, B., RICHARDS, C.S., HENDLER, F., BURNS, D. and GUSTERSON, B., Over-expression of the EGF receptor is a hallmark of squamous-cell carcinomas. J. Pathol., 149, 9-14 (1986).
17. PIM, D., COLLINS, M. and BANKS, L., Human-papillomavirus-type-16 E5 gene stimulates the transforming activity of the epidermal-growth-factor receptor. Oncogene, 7, 27-32 (1992).
18. SAINSBURY, J., MALCOLM, A., APPLETON, D., FARNDON, J. and HARRIS, A., Presence of epidermal-growth-factor receptor as an indicator of poor prognosis in patients with breast cancer. J. clin. Pathol., 38, 1225-1228 (1985).
19. SANTINI, D., CECCARELLI, C., MARTINELLI, G.N., LEONE, O., MARABINI, A., ORLANDI, C. and MANCINI, A., Immunocytochemical study of epidermal-growth-factor receptor, transforming growth factor alpha and "squamous differentiation" in human endometrial carcinoma. Hum. Pathol., 25, 1319-1323 (1994).
20. SPORN, M. and TODARO, G., Autocrine growth factors and cancer. Nature (Lond.), 313, 747-751 (1985).
21. VEALE, D., KERR, N., GIBSON, G.H. and HARRIS, A.L., Characterization of epidermal-growth-factor receptor in primary human non-small-cell lung cancer. Cancer Res., 49, 1313-1317 (1989).
22. WATSON, J., GILMAN, M., WITKOWSKI, J. and ZOLLER, M., Recombinant DNA, 2nd ed., pp. 315-346, W.H. Freeman, New York and Oxford (1993).